Na(+)-ATPase in spontaneous hypertensive rats: possible AT(1) receptor target in the development of hypertension

Biochim Biophys Acta. 2010 Mar;1798(3):360-6. doi: 10.1016/j.bbamem.2009.06.018. Epub 2009 Jun 26.

Abstract

Clinical and experimental data show an increase in sodium reabsorption on the proximal tubule (PT) in essential hypertension. It is well known that there is a link between essential hypertension and renal angiotensin II (Ang II). The present study was designed to examine ouabain-insensitive Na(+)-ATPase activity and its regulation by Ang II in spontaneously hypertensive rats (SHR). We observed that Na(+)-ATPase activity was enhanced in 14-week-old but not in 6-week-old SHR. The addition of Ang II from 10(-12) to 10(-6) mol/L decreased the enzyme activity in SHR to a level similar to that obtained in WKY. The Ang II inhibitory effect was completely reversed by a specific antagonist of AT(2) receptor, PD123319 (10(-8) mol/L) indicating that a system leading to activation of the enzyme in SHR is inhibited by AT(2)-mediated Ang II. Treatment of SHR with losartan for 10 weeks (weeks 4-14) prevents the increase in Na(+)-ATPase activity observed in 14-week-old SHR. These results indicate a correlation between AT(1) receptor activation in SHR and increased ouabain-insensitive Na(+)-ATPase activity. Our results open new possibilities towards our understanding of the pathophysiological mechanisms involved in the increased sodium reabsorption in PT found in essential hypertension.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Enzyme Activation / drug effects
  • Hypertension / enzymology*
  • Hypertension / pathology*
  • Kidney Tubules, Proximal / drug effects
  • Kidney Tubules, Proximal / enzymology
  • Kidney Tubules, Proximal / pathology
  • Kinetics
  • Losartan / pharmacology
  • Male
  • Ouabain / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Receptor, Angiotensin, Type 1 / metabolism*
  • Sodium-Potassium-Exchanging ATPase / metabolism*

Substances

  • Receptor, Angiotensin, Type 1
  • Angiotensin II
  • Ouabain
  • Sodium-Potassium-Exchanging ATPase
  • Losartan